Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Purkinje cell protein 2 (PCP2), commonly referred to as L7, is a signaling modulator primarily expressed in the Purkinje cells of the cerebellum and retinal ON bipolar cells. It functions as a regulator of G-protein signaling, specifically interacting with G-alpha-o and G-alpha-i subunits to modulate their nucleotide exchange and dissociation. In the cerebellum, PCP2 plays a critical role in motor coordination and learning by influencing synaptic plasticity, such as long-term depression (LTD) at parallel fiber-Purkinje cell synapses. Dysregulation or deficiency of PCP2 is associated with cerebellar ataxia and has been implicated in the pathophysiology of neurodevelopmental disorders like Fragile X syndrome. While not currently a primary target for approved small-molecule drugs, it is a significant target in neuroscience research for cell-specific genetic manipulation and potential gene therapy strategies for cerebellar disorders.
Acts as a cell-type specific modulator for G protein-mediated cell signaling, functioning as a guanine nucleotide dissociation inhibitor (GDI) or guanine nucleotide exchange factor (GEF) for G-alpha-o and G-alpha-i subunits.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purkinje cell protein 2 (PCP2) (PCP2).